Moreover, KRAS mutations have been identified in a high proportion of disseminated mucinous neoplasms (Tokunaga et al. 2019; Davison et al. 2014; Szych et al. 1999; Zauber et al. 2011; Tsai et al. 2019). Here, KRAS is linked to mucinous neoplasm.